Lonza to acquire Synaffix to strengthen ADC development
Synaffix’s technology platform is intended to enhance and extend Lonza’s integrated ADC services
Read More
Tag: Lonza
- R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment
- Taiwan Bio partners with Terumo to advance automated Treg manufacturing
- Elevara begins phase 2b trial of ELV001 in rheumatoid arthritis
- Lebrikizumab shows strong results for children with atopic dermatitis
- MHRA approves new treatment for severe alopecia areata
